Weekly Recap: Secondary offering to raise cash and Future Pak U.S. license

Jaguar Health, Inc. (NASDAQ:JAGX) is raising cash via a Sept. 3 secondary offering amid >$25M liabilities and liquidity strain while monetizing U.S. rights to Mytesi and Canalevia-CA1 with a $16M upfront deal with Future Pak and advancing crofelemer powder toward a mid—2027 NDA.Previous Week RecapT…